Genflow Biosciences Plc (GENF.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.89M |
| Enterprise Value | 7.78M |
| P/E Ratio | -7.95 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 17.77 |
| Price/Book Ratio | 48.42 |
| Enterprise/Revenue | 16.69 |
| Enterprise/EBITDA | -8.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.88 |
| Operating Margin | -2.14 |
AD
Management Effectiveness
| Return On Assets | -1.47 |
| Return On Equity | 6.1 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1,093 |
| EBITDA | -2M |
| Net Income | -1.42M |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 632,553 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.34 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | -20.45 |
| 52-Week High | 3.12 |
| 52-Week Low | 1.21 |
| Moving Average 50 Days | 1.98 |
| Moving Average 200 Days | 2.04 |
Statistics
| Average Volume | 2.46M |
| Shares Outstanding | 594.53M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
